GUANGZHOU HEGEYA BIOTECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

GUANGZHOU HEGEYA BIOTECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HOEGOA. The owner is based in GUANGZHOU.

RM 0586, ZONEC, 2/F, NO.8, SHENGTANG STREET, CENCUN, TIANHE DIST.

GUANGZHOU 510000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HOEGOA
HOEGOA
Registered 2024

Trademark Classifications

GUANGZHOU HEGEYA BIOTECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does GUANGZHOU HEGEYA BIOTECHNOLOGY CO., LTD. have?

GUANGZHOU HEGEYA BIOTECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does GUANGZHOU HEGEYA BIOTECHNOLOGY CO., LTD. file in?

GUANGZHOU HEGEYA BIOTECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 3 (Cosmetics & Cleaning). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are GUANGZHOU HEGEYA BIOTECHNOLOGY CO., LTD.'s most well-known trademarks?

GUANGZHOU HEGEYA BIOTECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as HOEGOA. These are among 1 currently registered trademark in the portfolio.

What is GUANGZHOU HEGEYA BIOTECHNOLOGY CO., LTD.'s trademark registration success rate?

GUANGZHOU HEGEYA BIOTECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.